In an update to the public last week, the FDA announced that all but one animal drug company have committed to seek withdrawal of approvals for any production uses of affected drug applications and change the remaining therapeutic uses of their products from over-the-counter to use by Veterinary Feed Directive or prescription. These changes stem from the implementation of FDA Guidance #213 that was announced in December of last year. The FDA is pleased with the strong responses received thus far and promises to continue to provide updates to the public. For the official announcement from the FDA, read here.
Industry Commitment For Antibiotic Resistance Strategy
Recent GVL Blog Posts
GVL SAHO Appreciation: Updates to NVAP Accreditation and ADT Reporting
October is State Animal Health Official (SAHO) appreciation month at GVL. Listen as our product manager, Stacey Noe, describes the updates we've made to our software platform to help SAHOs do their job more efficiently. Don't forget to explore our SAHO resource page,...
Interstate Travel and Movement Compliance for All Species – free CE webinar
In a previous webinar with Dr. Nelva Bryant entitled International Pet Movement 101, we discussed the various requirements and preparations needed for international travel with pets. This webinar focuses on traveling in the US with all types of animals and the various...
Riverside Animal Hospital, GVL Customer of the Month
Pictured above: back - Donna, Dr. Portnoy, Krista, Lisa, Emily, Jen, Dr. Watson, Dr. Gilmore; front - Nicole and Teddy Toodles, Amy, Megan, Francesca.Every month, we are featuring veterinary clinics and hospitals who utilize GVL in their practices. We look forward to...
